Chin Mark's Form 4 filing
Pyxis Oncology, Inc. (PYXS) · filed Apr 25, 2022
- Accession no.
- 0000899243-22-015542
- Filed
- Apr 25, 2022
- Trade date
- Apr 21, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $5.32M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Chin MarkCIK 0001734389 | Other: Former Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 21, 2022 | Common Stock | SSaleDisposed | −1,745,761 | $3.05 | −$5,324,571.05 | 0 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.